The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

Trial Profile

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Sargramostim (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 08 Jun 2017 Planned number of patients changed from 20 to 19.
    • 03 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top